SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 156 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $288,867 | +5.9% | 2,383 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $272,901 | -13.3% | 2,383 | +4.4% | 0.00% | -25.0% |
| Q1 2023 | $314,666 | +6.4% | 2,283 | 0.0% | 0.00% | +33.3% |
| Q4 2022 | $295,831 | +15.6% | 2,283 | -1.4% | 0.00% | 0.0% |
| Q3 2022 | $256,000 | +25500.0% | 2,316 | +4934.8% | 0.00% | – |
| Q2 2015 | $1,000 | -88.9% | 46 | -93.8% | 0.00% | – |
| Q1 2015 | $9,000 | -10.0% | 747 | +6.6% | 0.00% | – |
| Q4 2014 | $10,000 | -28.6% | 701 | 0.0% | 0.00% | – |
| Q3 2014 | $14,000 | -33.3% | 701 | -3.4% | 0.00% | -100.0% |
| Q2 2014 | $21,000 | -25.0% | 726 | -39.0% | 0.00% | 0.0% |
| Q1 2014 | $28,000 | – | 1,191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |